Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asma Beldi-Ferchiou

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 1, 2020
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress SyndromeSophie Hue, Asma Beldi-Ferchiou, Inés Bendib, et al.
Frontiers in Immunology|November 24, 2025
Skewed pretransplant lymphocytes subpopulations correlate with opportunistic infection onset within the first two years following kidney transplantationAsma Beldi-Ferchiou, Florence Runyo, Florence Canoui-Poitrine, et al.
British Journal of Haematology|February 16, 2019
Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphomaHsiling Chiu, Preeti Trisal, Chad Bjorklund, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantationAudrey Moatti, Anais Debesset, Caroline Pilon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2020
Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adultsJulie Oniszczuk, Asma Beldi-Ferchiou, Etienne Audureau, et al.
Blood Advances|April 12, 2018
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphomaMarie-Hélène Delfau-Larue, Axel van der Gucht, Jehan Dupuis, et al.
Ejhaem|September 2, 2022
Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosisHajer Abroud, Asma Beldi-Ferchiou, Vincent Audard, et al.
Blood Advances|July 17, 2020
Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE studyMarie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, et al.
Kidney International Reports|February 25, 2026
Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change DiseaseFelicitas E Hengel, Asma Beldi-Ferchiou, Hamza Sakhi, et al.
British Journal of Haematology|February 6, 2023
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group studyAsma Beldi-Ferchiou, Jean-Philippe Jais, Hervé Ghesquieres, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Respiratory and Critical Care Medicine|September 1, 2020
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress SyndromeSophie Hue, Asma Beldi-Ferchiou, Inés Bendib, et al.
Frontiers in Immunology|November 24, 2025
Skewed pretransplant lymphocytes subpopulations correlate with opportunistic infection onset within the first two years following kidney transplantationAsma Beldi-Ferchiou, Florence Runyo, Florence Canoui-Poitrine, et al.
British Journal of Haematology|February 16, 2019
Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphomaHsiling Chiu, Preeti Trisal, Chad Bjorklund, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantationAudrey Moatti, Anais Debesset, Caroline Pilon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2020
Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adultsJulie Oniszczuk, Asma Beldi-Ferchiou, Etienne Audureau, et al.
Blood Advances|April 12, 2018
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphomaMarie-Hélène Delfau-Larue, Axel van der Gucht, Jehan Dupuis, et al.
Ejhaem|September 2, 2022
Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosisHajer Abroud, Asma Beldi-Ferchiou, Vincent Audard, et al.
Blood Advances|July 17, 2020
Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE studyMarie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, et al.
Kidney International Reports|February 25, 2026
Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change DiseaseFelicitas E Hengel, Asma Beldi-Ferchiou, Hamza Sakhi, et al.
British Journal of Haematology|February 6, 2023
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group studyAsma Beldi-Ferchiou, Jean-Philippe Jais, Hervé Ghesquieres, et al.
Pageof 3